Gilead suspends business operations in Russia
6315
Friday, 25 March, 2022, 10:00
Gilead, a US biopharmaceutical company, has suspended all business operations in Russia that are not related to life-saving drugs. This is stated in the message on the company’s website.
The company announced the suspension of the creation of new centers for clinical trials in Moscow and Kyiv. In addition, the proceeds from the sale of medicines will be directed to humanitarian aid to Ukraine.
World-first virus therapy for esophageal cancer debuts in Japan
841523.08.2026, 22:30
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock more than doubles
901519.08.2026, 21:45
US revokes more than 600 visas to dismantle global 'birth tourism' networks
1127313.08.2026, 00:33
Sergey Khachatryan wins the 1st prize in the individual race (photo)
687912.08.2026, 23:18
WHO chief: US immunization changes ‘not aligned with decades of evidence’
955312.08.2026, 20:09
An Invasive Mosquito Is Spreading With Alarming Speed, Threatening Africa’s Cities
1145505.08.2026, 22:05
Healthy diet too expensive for one in three people globally, UN report finds
1900422.07.2026, 00:52
Confirmed Ebola cases in Democratic Republic of Congo rise to 1,963
1907414.07.2026, 16:34